Clinical Trial

Exploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma

Study acronym: FIL_MIMYC
Recruiting
View on ClinicalTrials.gov →
Summary
This is a observational, retrospective and prospective study designed to assess the potential correlations between MYC alterations, lymphoma mutational landscape and functional immune contextures in Diffuse Large B-cell Lymphoma or High-Grade B-cell Lymphoma
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2024-09-04; most recent amendment 2025-12-22.
Status change: Not Yet Recruiting → Recruiting 2025-09-04
Trial Details
NCT Number NCT06588205
Lead Sponsor Fondazione Italiana Linfomi - ETS
Conditions Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
Enrollment 200 participants
Start Date 2025-05-05
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-29